Jan Öhrström

Title: Jan Öhrström: Innovator in Medical Treatments

Introduction

Jan Öhrström is a notable inventor based in Mercer Island, WA (US). He has made significant contributions to the field of medical treatments, particularly in addressing B-cell malignancies and hemophilia B. With a total of 2 patents, Öhrström's work has the potential to impact many patients in need of effective therapies.

Latest Patents

Öhrström's latest patents include innovative methods for treating B-cell malignancies using a TACI-Ig fusion molecule. This invention provides methods and compositions for the treatment of B-cell malignancies, including non-Hodgkin's lymphoma, by administering a TACI-Ig fusion molecule to suppress the proliferation-inducing functions of BlyS and APRIL. Another significant patent is the method for treating hemophilia B, which involves the use of factor XIII in conjunction with factor IX to treat patients suffering from this condition.

Career Highlights

Throughout his career, Jan Öhrström has worked with prominent companies such as Zymogenetics, Inc. and Ares Trading S.a. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Öhrström has collaborated with notable professionals in his field, including Herve Broly and Arnaud Ythier. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jan Öhrström's contributions to medical treatments through his patents demonstrate his commitment to improving patient care. His innovative approaches to treating B-cell malignancies and hemophilia B highlight the importance of research and development in the medical field.